AzTrials
AzTrials

Gastrointestinal Motility DisorderNCT04764019

Intestinal Dysmotility in Patients With Functional Digestive Symptoms

A study testing High resolution intestinal manometry in people with Gastrointestinal Motility Disorder, run by Hospital Universitari Vall d'Hebron Research Institute at 1 site in Spain.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Automatic and non-invasive diagnostic methods based on the analysis of internal (intraluminal) and external (abdominal) images have been recently developed to measure intestinal motility. Read more about this study

Who is it for?
Ages 18 to 80 yearsHealthy volunteers can take part
Conditions the study is for
Gastrointestinal Motility Disorder
What is being tested?
High resolution intestinal manometry
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
1 siteSpain
Study dates
7 Nov 2018to 28 Feb 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Patients: digestive symptoms
  • Healthy subjects: asymptomatic

Who cannot join

  • Patients: organic disorders
  • Healthy subjects: organic disorders

Trial locations and contacts

1 site in 1 country.

Carolina Malagelada, MD contact

34 932746259

cmalagelada@vhebron.net

Fernando Azpiroz, MD contact

34932746259

azpiroz.fernando@gmail.com

Spain1 site, 1 recruiting
  • Hospital Vall d'Hebron

    Barcelona, 08035

    Carolina Malagelada, MD, 34 932746259, cmalagelada@vhebron.net

    Recruiting

Other trials in Spain

About this study

Automatic and non-invasive diagnostic methods based on the analysis of internal (intraluminal) and external (abdominal) images have been recently developed to measure intestinal motility. In patients with severe motor disorders, such as intestinal pseudo-obstruction, these new non-invasive techniques have shown to be equivalent to conventional intestinal manometry, the current gold-standard. However, these new techniques also detect less obvious signs of intestinal motor dysfunction, which are not detectable by conventional manometry.

High resolution manometry has been recently been applied to other parts of the digestive tract with great success, and probably will replace the actual gold-standard for intestinal motility evaluation. The investigators expect high-resolution manometry to be more sensitive than conventional manometry to the subtle motility disturbances detected by the new non-invasive techniques.

The purpose of this project is to demonstrate that intestinal motor function can be measured more sensitively and accurately using a combination of new technologies: high resolution manometry and the non-invasive diagnostic methods based on the analysis of images. The combined use of these techniques, following a step-wise algorithm, could allow to determine the mechanism, the affected regions and severity of the dysfunction in patients with intestinal dysmotility.

Being tested
High resolution intestinal manometry

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • High resolution intestinal manometryDiagnostic test

    Evaluation of intestinal manometry by the use a high resolution intestinal manometry catheter with 34 closely spaced sensors.

Study groups in NCT04764019
Study groupRoleWhat they receive
PatientsExperimentalPatients with chronic digestive symptoms in whom intestinal dysmotility is suspected
Receives: Diagnostic Test: High resolution intestinal manometry

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Contractile activity

    Number of contractions

    Measured: 10 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Feb 2021
  2. Study start7 Nov 2018
  3. Primary completion15 Jul 2021
  4. Study completion28 Feb 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04764019
Sponsor's protocol ID
PR(AG)56/2018
Status last verified
Mar 2021
First submitted
17 Feb 2021
Last updated
22 Nov 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Malagelada C, Karunaratne TB, Accarino A, Cogliandro RF, Landolfi S, Gori A, Boschetti E, Malagelada JR, Stanghellini V, Azpiroz F, De Giorgio R. Comparison between small bowel manometric patterns and full-thickness biopsy histopathology in severe intestinal dysmotility. Neurogastroenterol Motil. 2018 Mar;30(3). doi: 10.1111/nmo.13219. Epub 2017 Sep 22.

    PubMed 28941004
  • Alcala-Gonzalez LG, Nieto A, Accarino A, Azpiroz F, Malagelada C. High-resolution versus conventional manometry for the diagnosis of small bowel motor dysfunction. Neurogastroenterol Motil. 2024 Nov;36(11):e14907. doi: 10.1111/nmo.14907. Epub 2024 Sep 2.

    PubMed 39223844

Questions about this trial

What is this clinical trial studying?

A study testing High resolution intestinal manometry in people with Gastrointestinal Motility Disorder, run by Hospital Universitari Vall d'Hebron Research Institute at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 22 Nov 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Carolina Malagelada, MD (34 932746259, cmalagelada@vhebron.net), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Contractile activity (time frame: 10 minutes). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04764019, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Nov 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in